(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-[4-chloro-3-(4-ethoxybenzyl)phenyl]tetrahydropyran-3,4,5-triyl Triacetate；Dapagliflozin Intermediates
CAS:461432-25-7
Chemical Formula:C29H33ClO10
Molecular Weight:577.02
Availability: R&D; Commercialization
⬤ CAS No.461432-25-7
⬤ Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | Dapagliflozin Tetraacetate |
| CAS No. | 461432-25-7 |
| Chemical Formula | C29H33ClO10 |
| Molecular Weight | 577.02 |
| EINECS | 930-010-9 |
| Related Categories | Dapagliflozin Intermediates |
| Boiling Point | 626.8±55.0 °C(Predicted) |
| Density | 1.29±0.1 g/cm3(Predicted) |
| Vapor pressure | 0Pa at 25℃ |
| Storage conditions | Sealed in dry,Room Temperature |
| Solubility | Chloroform (dissolved in small amount), dichloromethane (dissolved in small amount), DMSO (small amount, sonicated) |
| Form | Powder |
| Stability | Stable under recommended storage conditions. |
| Note | It is used as a chemical intermediate for organic synthesis and experimental research. It is often used as an organic chemical raw material and can be used to make spices. It is also an intermediate for synthesizing various drugs in the pharmaceutical industry. |
| Core drug synthesis | Key intermediates for Dapagliflozin API |
| Key role in the synthesis process | Glycoside core structure construction |
| R&D and extended applications | Development of a new generation of SGLT2 inhibitors |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
Comparing Nifedipine & Amlodipine: Onset, duration, and side effects decoded. Demand for amlodipine intermediates? We deliver quality.
Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model.
This non-peptide GLP-1 receptor agonist, now in late-stage clinical trials, is redefining possibilities for diabetes and obesity treatment. Let’s unpack what makes it distinctive from both lab bench and manufacturing perspectives.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
